Health Cor Management, L.P. Agios Pharmaceuticals, Inc. Transaction History

Health Cor Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $79.8 Million - $93.9 Million	-1,532,960 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $23.7 Million - $30.8 Million	535,890 Added 53.75%	1,532,960 $79.2 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $33.1 Million - $46.4 Million	997,070 New	997,070 $43.2 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $14.1 Million - $21.9 Million	-408,844 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $9.09 Million - $15.5 Million	-288,546 Reduced 41.38%	408,844 $14.5 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $21 Million - $35.3 Million	697,390 New	697,390 $33.3 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.26B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.